A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer

  • Authors:
    • Yon Ko
    • Tanja Hahn
    • Hong Lu
    • Zhan Lu Ma
    • Jian Chen
    • Marcus Rothe
    • Alexandra Florin
    • Stefan Fronhoffs
    • Peter Albers
    • Agapios Sachinidis
    • Hans Vetter
    • Annette Kaminski
    • Peter Behrens
    • Axel Wellmann
    • Nicolas Wernert
  • View Affiliations

  • Published online on: February 1, 2005     https://doi.org/10.3892/ijmm.15.2.183
  • Pages: 183-196
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostate cancer is among the most common tumors in industrialized nations. However, little is known about the molecular events underlying its development. In the present study we used suppressive subtraction hybridization (SSH) in combination with laser-assisted microdissection in order to compare gene expression between prostate carcinoma and the normal prostate proper. Both are mixed tissues which consist of an epithelial and a stromal compartment. We first compared mRNA (cDNA) expression by SSH and then used real-time quantitative RT-PCR analysis of microdissected tissue probes in order to verify differential expression of subtracted cDNA clones. We also used differentially expressed cDNAs for the synthesis of radiolabelled riboprobes in order to attribute differential expression to specific cell types in tissue sections by in situ hybridization. Using this approach we found an up-regulation of ubiquitin carboxyl extension protein 1 (UBCEP-1) mRNA in prostate carcinoma cells compared to the normal glandular epithelium of the prostate proper. UBCEP-1 mediated ubiquitin chain elongation may promote prostate carcinoma development by increasing via the proteasome pathway the degradation of proteins which are involved in growth inhibition or apoptosis.

Related Articles

Journal Cover

February 2005
Volume 15 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ko Y, Hahn T, Lu H, Ma Z, Chen J, Rothe M, Florin A, Fronhoffs S, Albers P, Sachinidis A, Sachinidis A, et al: A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer. Int J Mol Med 15: 183-196, 2005.
APA
Ko, Y., Hahn, T., Lu, H., Ma, Z., Chen, J., Rothe, M. ... Wernert, N. (2005). A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer. International Journal of Molecular Medicine, 15, 183-196. https://doi.org/10.3892/ijmm.15.2.183
MLA
Ko, Y., Hahn, T., Lu, H., Ma, Z., Chen, J., Rothe, M., Florin, A., Fronhoffs, S., Albers, P., Sachinidis, A., Vetter, H., Kaminski, A., Behrens, P., Wellmann, A., Wernert, N."A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer". International Journal of Molecular Medicine 15.2 (2005): 183-196.
Chicago
Ko, Y., Hahn, T., Lu, H., Ma, Z., Chen, J., Rothe, M., Florin, A., Fronhoffs, S., Albers, P., Sachinidis, A., Vetter, H., Kaminski, A., Behrens, P., Wellmann, A., Wernert, N."A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer". International Journal of Molecular Medicine 15, no. 2 (2005): 183-196. https://doi.org/10.3892/ijmm.15.2.183